Differential Effects of 2-oxo Acids on Pyruvate Utilization and Fatty Acid Synthesis in Rat Brain

Overview

Journal Biochem J

Specialty Biochemistry

Date 1974 Apr 1

PMID 4155948

Citations 15

Authors

J B Clark

J M Land

Affiliations

Soon will be listed here.

Abstract

1. The effects of 2-oxo-4-methylpentanoate, 2-oxo-3-methylbutanoate and 2-oxo-3-methylpentanoate on the activity of pyruvate dehydrogenase (EC 1.2.4.1), citrate synthase (EC 4.1.3.7), acetyl-CoA carboxylase, (EC 6.4.1.2) and fatty acid synthetase derived from the brains of 14-day-old rats were investigated. 2. The pyruvate dehydrogenase enzyme activity was competitively inhibited by 2-oxo-3-methylbutanoate with respect to pyruvate with a K(i) of 2.04mm but was unaffected by 2-oxo-4-methylpentanoate or 2-oxo-3-methylpentanoate. 3. The citrate synthase activity was inhibited competitively (with respect to acetyl-CoA) by 2-oxo-4-methylpentanoate (K(i)~7.2mm) and 2-oxo-3-methylbutanoate (K(i)~14.9mm) but not by 2-oxo-3-methylpentanoate. 4. The acetyl-CoA carboxylase activity was not inhibited significantly by any of the 2-oxo acids investigated. 5. The fatty acid synthetase activity was competitively inhibited (with respect to acetyl-CoA) by 2-oxo-4-methylpentanoate (K(i)~930mum) and 2-oxo-3-methylpentanoate (K(i)~3.45mm) but not by 2-oxo-3-methylbutanoate. 6. Preliminary experiments indicate that 2-oxo-4-methylpentanoate and 2-oxo-3-phenylpropionate (phenylpyruvate) significantly inhibit the ability of intact brain mitochondria from 14-day-old rats to oxidize pyruvate. 7. The results are discussed with reference to phenylketonuria and maple-syrup-urine disease. A biochemical mechanism is proposed to explain the characteristics of these diseases.

Citing Articles

Regulation of substrate utilization by the mitochondrial pyruvate carrier.

Vacanti N, Divakaruni A, Green C, Parker S, Henry R, Ciaraldi T Mol Cell. 2014; 56(3):425-435.

PMID: 25458843 PMC: 4267523. DOI: 10.1016/j.molcel.2014.09.024.

Staphylococcus aureus sepsis induces early renal mitochondrial DNA repair and mitochondrial biogenesis in mice.

Bartz R, Fu P, Suliman H, Crowley S, MacGarvey N, Welty-Wolf K PLoS One. 2014; 9(7):e100912.

PMID: 24988481 PMC: 4079589. DOI: 10.1371/journal.pone.0100912.

The long and winding road to the mitochondrial pyruvate carrier.

Schell J, Rutter J Cancer Metab. 2013; 1(1):6.

PMID: 24280073 PMC: 3834494. DOI: 10.1186/2049-3002-1-6.

Mitochondrial impairment increases FL-PINK1 levels by calcium-dependent gene expression.

Gomez-Sanchez R, Gegg M, Bravo-San Pedro J, Niso-Santano M, Alvarez-Erviti L, Pizarro-Estrella E Neurobiol Dis. 2013; 62:426-40.

PMID: 24184327 PMC: 3898697. DOI: 10.1016/j.nbd.2013.10.021.

Biochemical correlates of neuropsychiatric illness in maple syrup urine disease.

Muelly E, Moore G, Bunce S, Mack J, Bigler D, Morton D J Clin Invest. 2013; 123(4):1809-20.

PMID: 23478409 PMC: 3613932. DOI: 10.1172/JCI67217.

References

DENT C, WESTALL R . Studies in maple syrup urine disease. Arch Dis Child. 1961; 36:259-68. PMC: 2012780. DOI: 10.1136/adc.36.187.259. View

Dreyfus P, Prensky A . Further observations on the biochemical lesion in maple syrup urine disease. Nature. 1967; 214(5085):276. DOI: 10.1038/214276a0. View

Silberberg D . Maple syrup urine disease metabolites studies in cerebellum cultures. J Neurochem. 1969; 16(7):1141-6. DOI: 10.1111/j.1471-4159.1969.tb05959.x. View

DANCIS J, HUTZLER J, Levitz M . THE DIAGNOSIS OF MAPLE SYRUP URINE DISEASE (BRANCHED- CHAIN KETOACIDURIA) BY THE IN VITRO STUDY OF THE PERIPHERAL LEUKOCYTE. Pediatrics. 1963; 32:234-8. View

DANCIS J, Levitz M, WESTALL R . Maple syrup urine disease: branched-chain keto-aciduria. Pediatrics. 1960; 25:72-9. View

Bowden J, Brestel E, Cope W, McArthur 3rd C, Westfall D, Fried M . -Ketoisocaproic acid inhibition of pyruvate and -ketoglutarate oxidative decarboxylation in rat liver slices. Biochem Med. 1970; 4(1):69-76. DOI: 10.1016/0006-2944(70)90104-3. View

PATRICK A . Maple syrup urine disease. Arch Dis Child. 1961; 36:269-72. PMC: 2012762. DOI: 10.1136/adc.36.187.269. View

Blass J, Lewis C . Kinetic properties of the partially purified pyruvate dehydrogenase complex of ox brain. Biochem J. 1973; 131(1):31-7. PMC: 1177436. DOI: 10.1042/bj1310031. View

Land J, Clark J . Effect of phenylpyruvate on enzymes involved in fatty acid synthesis in rat brain. Biochem J. 1973; 134(2):545-55. PMC: 1177842. DOI: 10.1042/bj1340545. View

10.

Bowden J, McArthur 3rd C, Fried M . The inhibition of pyruvate decarboxylation in rat brain by -ketoisocaproic acid. Biochem Med. 1971; 5(2):101-8. DOI: 10.1016/0006-2944(71)90079-2. View

11.

Chance B, Williams G . The respiratory chain and oxidative phosphorylation. Adv Enzymol Relat Subj Biochem. 1956; 17:65-134. DOI: 10.1002/9780470122624.ch2. View

12.

Bowden J, CONNELLY J . Branched chain alpha-keto acid metabolism. II. Evidence for the common identity of alpha-ketoisocaproic acid and alpha-keto-beta-methyl-valeric acid dehydrogenases. J Biol Chem. 1968; 243(12):3526-31. View

13.

Saggerson E, Greenbaum A . The regulation of triglyceride synthesis and fatty acid synthesis in rat epididymal adipose tissue. Effects of altered dietary and hormonal conditions. Biochem J. 1970; 119(2):221-42. PMC: 1179344. DOI: 10.1042/bj1190221. View

14.

Cleland W . Computer programmes for processing enzyme kinetic data. Nature. 1963; 198:463-5. DOI: 10.1038/198463a0. View

15.

Kanzaki T, Hayakawa T, Hamada M, Fukuyoshi Y, Koike M . Mammalian alpha-keto acid dehydrogenase complexes. IV. Substrate specificities and kinetic properties of the pig heart pyruvate and 2-oxyoglutarate dehydrogenase complexes. J Biol Chem. 1969; 244(5):1183-7. View

16.

Wohlhueter R, HARPER A . Coinduction of rat liver branched chain alpha-keto acid dehydrogenase activities. J Biol Chem. 1970; 245(9):2391-401. View

17.

Johnson W, CONNELLY J . Cellular localization and characterization of bovine liver branched-chain -keto acid dehydrogenases. Biochemistry. 1972; 11(10):1967-73. DOI: 10.1021/bi00760a036. View

18.

Patel M, AUERBACH V, Grover W, Wilbur D . Effect of the branched-chain alpha-keto acids on pyruvate metabolism by homogenates of human brain. J Neurochem. 1973; 20(6):1793-6. DOI: 10.1111/j.1471-4159.1973.tb00298.x. View

19.

MENKES J, HURST P, Craig J . A new syndrome: progressive familial infantile cerebral dysfunction associated with an unusual urinary substance. Pediatrics. 1954; 14(5):462-7. View

20.

Clark J, Nicklas W . The metabolism of rat brain mitochondria. Preparation and characterization. J Biol Chem. 1970; 245(18):4724-31. View